NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
23/03/2024
Voltar para busca
Dado oficial do USPTO
MEDAVAIL MEDCENTER
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
MEDAVAIL MEDCENTER
ST13
US500000085834503Classe
9
Pedido
85834503
Registro
4548631
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
36
Atualização mais recente
23/03/2024
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
9
Data de depósito
28/01/2013
Data de registro
10/06/2014
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
23/03/2024
Última transação
23/03/2024
Escritório responsável
United States Patent and Trademark Office
Código da situação
800
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
10/08/2013
Primeiro uso no comércio
10/08/2013
Código do desenho
4
Tipo de titular
03
Localização do titular
Mississauga, Ontario, CA
Examinador
MURRAY, DAVID T
Unidade examinadora
M40
Localização atual
GENERIC WEB UPDATE
Titulares e representantes
Titulares
MedAvail, Inc.
Representantes
Bradley K. DeSandro DESANDRO LAW GROUP PLLC
Classificação técnica
Classes Nice
Classe 9
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 9
Computer application software for dispensers that count or measure outputsoftware for dispensers that count or measure output for use with over-the-counter and behind-the-counter drugs and pharmaceuticalseach dispenser being a remote dispensing unit as remote dispensing technology for the prescriptionover-the-counter and behind-the-counter drugs and pharmaceuticalseach remote dispensing unit being networked across networked platforms in pharmacy enterpriseseach pharmacy enterprise supplying such drugs and pharmaceuticals via its pharmaceutical supply chain to each of the networked remote dispensing unitseach of the networked remote dispensing units being controlled by the pharmacy enterprise's pharmacists and pharmacy technicians to (i) dispense such drugs and pharmaceuticals to its end user customers; and (ii) facilitate live communications between pharmacists and pharmacy technicians and their end user customers so as to disseminate information concerning patient care to its end user customers; Dispensers that count or measure output for use with over-the-counter and behind-the-counter drugs and pharmaceuticalseach dispenser being a remote dispensing unit as remote dispensing technology for the prescriptionover-the-counter and behind-the-counter drugs and pharmaceuticalseach remote dispensing unit being networked across networked platforms in pharmacy enterpriseseach pharmacy enterprise supplying such drugs and pharmaceuticals via its pharmaceutical supply chain to each of the networked remote dispensing unitseach of the networked remote dispensing units being controlled by the pharmacy enterprise's pharmacists and pharmacy technicians to (i) dispense such drugs and pharmaceuticals to its end user customers; and (ii) facilitate live communications between pharmacists and pharmacy technicians and their end user customers so as to disseminate information concerning patient care to its end user customers
Publicações
Histórico de despachos e eventos da marca no USPTO.
36 publicações encontradas
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
23/03/2024
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
23/03/2024
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
22/03/2024
PR89
POST REGISTRATION ACTION MAILED - SEC. 8 & 9
21/03/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
20/03/2024
E89R
TEAS SECTION 8 & 9 RECEIVED
18/10/2023
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
10/06/2023
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
19/02/2021
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
19/02/2021
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
17/02/2021
E815
TEAS SECTION 8 & 15 RECEIVED
10/11/2020
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
10/06/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
10/06/2014
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
03/05/2014
REGV
LAW OFFICE REGISTRATION REVIEW COMPLETED
02/05/2014
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
29/04/2014
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
29/04/2014
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
29/04/2014
ALIE
ASSIGNED TO LIE
10/04/2014
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
28/03/2014
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/11/2013
GNRT
NON-FINAL ACTION E-MAILED
01/11/2013
CNRT
SU - NON-FINAL ACTION - WRITTEN
01/11/2013
SUPC
STATEMENT OF USE PROCESSING COMPLETE
31/10/2013
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
25/10/2013
IUAF
USE AMENDMENT FILED
30/09/2013
EISU
TEAS STATEMENT OF USE RECEIVED
30/09/2013
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
13/08/2013
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
18/06/2013
PUBO
PUBLISHED FOR OPPOSITION
18/06/2013
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
29/05/2013
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/05/2013
DOCK
ASSIGNED TO EXAMINER
09/05/2013
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/02/2013
NWAP
NEW APPLICATION ENTERED
31/01/2013
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace MEDAVAIL MEDCENTER ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.